Medscape6d
Ceftobiprole: A Novel, Broad-spectrum Cephalosporin with Activity against Methicillin-resistant Staphylococcus aureus
Conclusion. Ceftobiprole is a novel, broad-spectrum, parenteral cephalosporin undergoing Phase III clinical trials. Its broad spectrum of activity makes it a candidate for monotherapy of cSSSIs ...
Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole)
Innoviva Specialty Therapeutics, Inc., ("IST") a subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced it has entered ...
cnbctv185d
FDC gets USFDA approval for Cefixime 400 mg tablets to treat bacterial infections
Cefixime is used to treat bacterial infections in many different parts of the body. It belongs to the class of medicines ...
Innoviva enters distribution, license agreement with Basilea for Zevtera
Innoviva (INVA) announced it has entered into an exclusive distribution and license agreement with Basilea Pharmaceutica for the commercialization of Zevtera, an advanced-generation cephalosporin ...
Innoviva In Deal With Basilea Pharma To Buy U.S. Marketing Rights For Zevtera
Innoviva, Inc. (INVA) announced Monday that its unit Innoviva Specialty Therapeutics, Inc. or IST has entered into an exclusive ...
Too Old to Operate3d
Cloudy Effluent Has High Predictive Value in Peritoneal Dialysis-Associated Peritonitis
Research shows the presence of cloudy effluent in peritoneal dialysis-associated peritonitis is highly predictive of ...
Medscape8d
Cephalosporins vs. Penicillin for Group A Strep Pharyngitis
Many authors have suggested using a cephalosporin as an alternative to penicillin. Casey and Pichichero performed a meta-analysis of 35 randomized, controlled trials comparing penicillin with ...